Aurora Cannabis (TSE:ACB) Hits New 52-Week Low – Time to Sell?

Aurora Cannabis Inc. (TSE:ACB)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as C$0.00 and last traded at C$7.11, with a volume of 115417 shares trading hands. The stock had previously closed at C$7.37.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. ATB Capital decreased their price objective on shares of Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday, December 17th. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. Finally, Atb Cap Markets upgraded shares of Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th.

Aurora Cannabis Stock Down 4.6 %

The stock has a market cap of C$384.60 million, a price-to-earnings ratio of -8.68 and a beta of 2.71. The stock has a 50 day simple moving average of C$6.80 and a 200 day simple moving average of C$7.15. The company has a quick ratio of 2.48, a current ratio of 3.42 and a debt-to-equity ratio of 18.72.

Insider Buying and Selling

In related news, Senior Officer Andre Jerome sold 13,390 shares of the company’s stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of C$9.30, for a total value of C$124,524.32.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.